Clinical Trial Update: Safety of RSV Preventive Monoclonal Antibody [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing the safety of an RSV preventive monoclonal antibody. The study is currently recruiting and monitors adverse events, including fev…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• RSV preventive monoclonal antibody

Snippet

Sponsor: Duke University | Conditions: Fever, Adverse Event Following Immunisation | Phase 4 | Status: RECRUITING